Previous Article | Next Article 
Molecular and Cellular Biology, December 2002, p. 8601-8611, Vol. 22, No. 24
0270-7306/02/$04.00+0 DOI: 10.1128/MCB.22.24.8601-8611.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
A C-Terminal Inhibitory Domain Controls the Activity of p63 by an Intramolecular Mechanism
Zach Serber,1 Helen C. Lai,1 Annie Yang,2 Horng D. Ou,1 Martina S. Sigal,3 Alexander E. Kelly,1 Beatrice D. Darimont,4 Pascal H. G. Duijf,5 Hans van Bokhoven,5 Frank McKeon,2 and Volker Dötsch3*
Graduate Group in Biophysics,1
Departments of Pharmaceutical Chemistry and Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, California 94143,3
Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115,2
Department of Biology, University of Oregon, Eugene, Oregon 97403,4
Department of Human Genetics, University Medical Centre Nijmegen, 6500 HB Nijmegen, The Netherlands5
Received 7 March 2002/
Returned for modification 8 May 2002/
Accepted 23 September 2002
The human genome is far smaller than originally estimated, and one explanation is that alternative splicing creates greater proteomic complexity than a simple count of open reading frames would suggest. The p53 homologue p63, for example, is a tetrameric transcription factor implicated in epithelial development and expressed as at least six isoforms with widely differing transactivation potential. In particular, p63
isoforms contain a 27-kDa C-terminal region that drastically reduces their activity and is of clear biological importance, since patients with deletions in this C terminus have phenotypes very similar to patients with mutations in the DNA-binding domain. We have identified a novel domain within this C terminus that is necessary and sufficient for transcriptional inhibition and which acts by binding to a region in the N-terminal transactivation domain of p63 homologous to the MDM2 binding site in p53. Based on this mechanism, we provide a model that explains the transactivation potential of homo- and heterotetramers composed of different p63 isoforms and their effect on p53.
* Corresponding author. Mailing address: Departments of Pharmaceutical Chemistry and Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA 94143. Phone: (415) 502-7050. Fax: (415) 476-0688. E-mail:
volker{at}picasso.ucsf.edu.
Molecular and Cellular Biology, December 2002, p. 8601-8611, Vol. 22, No. 24
0022-538X/02/$04.00+0 DOI: 10.1128/MCB.22.24.8601-8611.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Mangiulli, M., Valletti, A., Caratozzolo, M. F., Tullo, A., Sbisa, E., Pesole, G., D'Erchia, A. M.
(2009). Identification and functional characterization of two new transcriptional variants of the human p63 gene. Nucleic Acids Res
37: 6092-6104
[Abstract]
[Full Text]
-
Tozluoglu, M., Karaca, E., Haliloglu, T., Nussinov, R.
(2008). Cataloging and organizing p73 interactions in cell cycle arrest and apoptosis. Nucleic Acids Res
36: 5033-5049
[Abstract]
[Full Text]
-
Rinne, T., Clements, S. E., Lamme, E., Duijf, P. H.G., Bolat, E., Meijer, R., Scheffer, H., Rosser, E., Tan, T. Y., McGrath, J. A., Schalkwijk, J., Brunner, H. G., Zhou, H., van Bokhoven, H.
(2008). A novel translation re-initiation mechanism for the p63 gene revealed by amino-terminal truncating mutations in Rapp-Hodgkin/Hay-Wells-like syndromes. Hum Mol Genet
17: 1968-1977
[Abstract]
[Full Text]
-
MacPartlin, M., Zeng, S. X., Lu, H.
(2008). Phosphorylation and Stabilization of TAp63{gamma} by I{kappa}B Kinase-{beta}. J. Biol. Chem.
283: 15754-15761
[Abstract]
[Full Text]
-
Lo Iacono, N., Mantero, S., Chiarelli, A., Garcia, E., Mills, A. A., Morasso, M. I., Costanzo, A., Levi, G., Guerrini, L., Merlo, G. R.
(2008). Regulation of Dlx5 and Dlx6 gene expression by p63 is involved in EEC and SHFM congenital limb defects. Development
135: 1377-1388
[Abstract]
[Full Text]
-
Petitjean, A., Ruptier, C., Tribollet, V., Hautefeuille, A., Chardon, F., Cavard, C., Puisieux, A., Hainaut, P., Caron de Fromentel, C.
(2008). Properties of the six isoforms of p63: p53-like regulation in response to genotoxic stress and cross talk with {Delta}Np73. Carcinogenesis
29: 273-281
[Abstract]
[Full Text]
-
Livera, G., Petre-Lazar, B., Guerquin, M.-J., Trautmann, E., Coffigny, H., Habert, R.
(2008). p63 null mutation protects mouse oocytes from radio-induced apoptosis. Reproduction
135: 3-12
[Abstract]
[Full Text]
-
Sayan, B. S., Sayan, A. E., Yang, A. L., Aqeilan, R. I., Candi, E., Cohen, G. M., Knight, R. A., Croce, C. M., Melino, G.
(2007). Cleavage of the transactivation-inhibitory domain of p63 by caspases enhances apoptosis. Proc. Natl. Acad. Sci. USA
104: 10871-10876
[Abstract]
[Full Text]
-
Malaguarnera, R, Vella, V, Vigneri, R, Frasca, F
(2007). p53 family proteins in thyroid cancer. Endocr Relat Cancer
14: 43-60
[Abstract]
[Full Text]
-
Caserta, T. M., Kommagani, R., Yuan, Z., Robbins, D. J., Mercer, C. A., Kadakia, M. P.
(2006). p63 Overexpression Induces the Expression of Sonic Hedgehog. Mol Cancer Res
4: 759-768
[Abstract]
[Full Text]
-
Rossi, M., Aqeilan, R. I., Neale, M., Candi, E., Salomoni, P., Knight, R. A., Croce, C. M., Melino, G.
(2006). The E3 ubiquitin ligase Itch controls the protein stability of p63. Proc. Natl. Acad. Sci. USA
103: 12753-12758
[Abstract]
[Full Text]
-
Antonini, D., Rossi, B., Han, R., Minichiello, A., Di Palma, T., Corrado, M., Banfi, S., Zannini, M., Brissette, J. L., Missero, C.
(2006). An Autoregulatory Loop Directs the Tissue-Specific Expression of p63 through a Long-Range Evolutionarily Conserved Enhancer. Mol. Cell. Biol.
26: 3308-3318
[Abstract]
[Full Text]
-
Nguyen, B.-C., Lefort, K., Mandinova, A., Antonini, D., Devgan, V., Della Gatta, G., Koster, M. I., Zhang, Z., Wang, J., di Vignano, A. T., Kitajewski, J., Chiorino, G., Roop, D. R., Missero, C., Dotto, G. P.
(2006). Cross-regulation between Notch and p63 in keratinocyte commitment to differentiation. Genes Dev.
20: 1028-1042
[Abstract]
[Full Text]
-
Yan, W., Chen, X.
(2006). GPX2, a Direct Target of p63, Inhibits Oxidative Stress-induced Apoptosis in a p53-dependent Manner. J. Biol. Chem.
281: 7856-7862
[Abstract]
[Full Text]
-
Testoni, B., Mantovani, R.
(2006). Mechanisms of transcriptional repression of cell-cycle G2/M promoters by p63. Nucleic Acids Res
34: 928-938
[Abstract]
[Full Text]
-
Helton, E. S., Zhu, J., Chen, X.
(2006). The Unique NH2-terminally Deleted ({Delta}N) Residues, the PXXP Motif, and the PPXY Motif Are Required for the Transcriptional Activity of the {Delta}N Variant of p63. J. Biol. Chem.
281: 2533-2542
[Abstract]
[Full Text]
-
King, K.E., Ponnamperuma, R.M., Gerdes, M.J., Tokino, T., Yamashita, T., Baker, C.C., Weinberg, W.C.
(2006). Unique domain functions of p63 isotypes that differentially regulate distinct aspects of epidermal homeostasis. Carcinogenesis
27: 53-63
[Abstract]
[Full Text]
-
Malaguarnera, R., Mandarino, A., Mazzon, E., Vella, V., Gangemi, P., Vancheri, C., Vigneri, P., Aloisi, A., Vigneri, R., Frasca, F.
(2005). The p53-homologue p63 may promote thyroid cancer progression. Endocr Relat Cancer
12: 953-971
[Abstract]
[Full Text]
-
Payne, A. S., Yan, A. C., Ilyas, E., Li, W., Seykora, J. T., Young, T. L., Pawel, B. R., Honig, P. J., Camacho, J., Imaizumi, S., Heymann, W. R., Schnur, R. E.
(2005). Two Novel TP63 Mutations Associated With the Ankyloblepharon, Ectodermal Defects, and Cleft Lip and Palate Syndrome: A Skin Fragility Phenotype. Arch Dermatol
141: 1567-1573
[Abstract]
[Full Text]
-
MacPartlin, M., Zeng, S., Lee, H., Stauffer, D., Jin, Y., Thayer, M., Lu, H.
(2005). p300 Regulates p63 Transcriptional Activity. J. Biol. Chem.
280: 30604-30610
[Abstract]
[Full Text]
-
Osada, M., Park, H. L., Nagakawa, Y., Yamashita, K., Fomenkov, A., Kim, M. S., Wu, G., Nomoto, S., Trink, B., Sidransky, D.
(2005). Differential Recognition of Response Elements Determines Target Gene Specificity for p53 and p63. Mol. Cell. Biol.
25: 6077-6089
[Abstract]
[Full Text]
-
Ying, H., Chang, D. L. F., Zheng, H., McKeon, F., Xiao, Z.-X. J.
(2005). DNA-Binding and Transactivation Activities Are Essential for TAp63 Protein Degradation. Mol. Cell. Biol.
25: 6154-6164
[Abstract]
[Full Text]
-
Liu, G., Chen, X.
(2005). The C-terminal Sterile {alpha} Motif and the Extreme C Terminus Regulate the Transcriptional Activity of the {alpha} Isoform of p73. J. Biol. Chem.
280: 20111-20119
[Abstract]
[Full Text]
-
Hanamoto, T., Ozaki, T., Furuya, K., Hosoda, M., Hayashi, S., Nakanishi, M., Yamamoto, H., Kikuchi, H., Todo, S., Nakagawara, A.
(2005). Identification of Protein Kinase A Catalytic Subunit {beta} as a Novel Binding Partner of p73 and Regulation of p73 Function. J. Biol. Chem.
280: 16665-16675
[Abstract]
[Full Text]
-
Johnson, R. A., Shepard, E. M., Scotto, K. W.
(2005). Differential Regulation of MDR1 Transcription by the p53 Family Members: ROLE OF THE DNA BINDING DOMAIN. J. Biol. Chem.
280: 13213-13219
[Abstract]
[Full Text]
-
Wu, G., Osada, M., Guo, Z., Fomenkov, A., Begum, S., Zhao, M., Upadhyay, S., Xing, M., Wu, F., Moon, C., Westra, W. H., Koch, W. M., Mantovani, R., Califano, J. A., Ratovitski, E., Sidransky, D., Trink, B.
(2005). {Delta}Np63{alpha} Up-Regulates the Hsp70 Gene in Human Cancer. Cancer Res.
65: 758-766
[Abstract]
[Full Text]
-
Calabro, V., Mansueto, G., Santoro, R., Gentilella, A., Pollice, A., Ghioni, P., Guerrini, L., La Mantia, G.
(2004). Inhibition of p63 Transcriptional Activity by p14ARF: Functional and Physical Link between Human ARF Tumor Suppressor and a Member of the p53 Family. Mol. Cell. Biol.
24: 8529-8540
[Abstract]
[Full Text]
-
Jacobs, W. B., Walsh, G. S., Miller, F. D.
(2004). Neuronal Survival and p73/p63/p53: A Family Affair. Neuroscientist
10: 443-455
[Abstract]
-
Moll, U. M., Slade, N.
(2004). p63 and p73: Roles in Development and Tumor Formation. Mol Cancer Res
2: 371-386
[Abstract]
[Full Text]
-
Westfall, M. D., Pietenpol, J. A.
(2004). p63: molecular complexity in development and cancer. Carcinogenesis
25: 857-864
[Abstract]
[Full Text]
-
Liu, G., Nozell, S., Xiao, H., Chen, X.
(2004). {Delta}Np73{beta} Is Active in Transactivation and Growth Suppression. Mol. Cell. Biol.
24: 487-501
[Abstract]
[Full Text]